Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT04179773 2025-01-14

CHIMIOSE

Terminated

7 enrolled

Gastrointestinal

Fibrosis, Liver Cirrhosis, Neoplasms, Colorectal Neoplasms

NCT05184283 2023-12-07

Utilization of MAsS in Patients Undergoing LT for HCC

Terminated

11 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT00465842 2019-02-15

Protein Biomarker in Hepatocellular Carcinoma

Terminated

211 enrolled

Gastrointestinal

Hepatitis, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT01686880 2015-07-01

TRYPHON

Phase 2 Terminated

10 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT00763776 2014-02-27

SECCI

Phase NA Terminated

27 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT00151671 2012-02-27

IMPACT

Phase 2/3 Terminated

35 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT00470340 2011-05-05

GEMOXIAL

Phase 3 Terminated

263 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Neoplasm Recurrence, Local, Recurrence

NCT00355212 2006-07-25

Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma

Phase 3 Terminated

240 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Clinical Trials

STOP-HCC

CHIMIOSE

Utilization of MAsS in Patients Undergoing LT for HCC

Protein Biomarker in Hepatocellular Carcinoma

TRYPHON

SECCI

IMPACT

GEMOXIAL

Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma